METHOD FOR DETECTING LEPTIN RECEPTOR LIGANDS Russian patent published in 2009 - IPC G01N33/50 C12N15/62 C07K14/715 

Abstract RU 2373534 C2

FIELD: medicine.

SUBSTANCE: invention refers to biotechnology and can be used for screening of compounds with properties of agonists or antagonists of leptin receptor. There is disclosed method for detecting leptin receptor definition that provides contact of a candidate compound and cells expressing after contransfection with two expressing vectors, respectively, two fused proteins, one of which consists of a short isoform of leptin receptor (OBRs) and an energy donor protein (preferentially luciferase), and the second - of OBRs and an energy acceptor protein (preferentially GFP or its mutant form); measurement of energy transfer (BRET) between the fused proteins; comparison of its value to the relevant indicator measured in the same system, however without tested compound, and estimated result where higher energy transfer indicates binding of the candidate compound-candidate with leptin receptor. Prospective application of the invention is related to development of the preparations for prevention or treatment of disease wherein leptin or its receptor are involved.

EFFECT: development of effective method for detecting leptin receptor ligands.

4 cl, 15 dwg, 3 ex

Similar patents RU2373534C2

Title Year Author Number
METHOD OF PRODUCING SIALYLATED OLIGOSACCHARIDES 2007
  • Samen Ehrik
RU2473695C2
SOLUBLE POLYPEPTIDE FRACTION OF PROTEIN LAG-3, METHOD OF PREPARING, THERAPEUTICAL COMPOSITION, ANTIBODY 1995
  • For Florans
  • Ehrsen T'Erri
  • Juar Bertran
  • Triebel' Frederik
RU2178306C2
ANTI-CXCR4 ANTIBODIES FOR TREATMENT OF HIV INFECTION 2010
  • Klinger-Amur Kristin
RU2573902C2
ANTI-CXCR4 ANTIBODIES AND USING THEM FOR TREATING CANCER 2009
  • Klinger-Amur Kristin
  • Gren'E-Kossanel' Veronik
RU2573897C2
ANTIBODIES TO BTN3A AND THEIR USE IN THE TREATMENT OF CANCER OR INFECTIOUS DISEASES 2019
  • Truneh, Alemseged
  • Olive, Daniel
  • Pasero, Christine
  • De Gassart, Aude
RU2800726C2
POLYNUCLEOTIDE MODULATING CANCER CELL PROLIFERATION (VARIANTS), POLYPEPTIDE, MONOCLONAL ANTIBODY, EXPRESSION VECTOR, HOST CELL, PHARMACEUTICAL AGENT FOR TREATMENT OF PROLIFERATIVE DISEASE, PHARMACEUTICAL COMPOSITION, POLYPEPTIDE USES IN PHARMACEUTICAL AGENT PRODUCTION 2002
  • Ferrandi Ehrik
  • Kamara I Ferrer Khose-Antonio
  • Martine Zhan
  • Tjur'O Kristof
RU2307666C2
ANTIBODIES SPECIFIC TO BTN2 AND THEIR APPLICATIONS 2018
  • Olive, Daniel
  • Pasero, Christine
RU2794996C2
BTN2-SPECIFIC ANTIBODIES AND USE THEREOF 2020
  • Foucher, Etienne
  • Cano, Carla
  • Le, Kieu Suong
  • Pasero, Christine
  • Olive, Daniel
RU2821703C2
HUMANISED ANTI-CXCR4 ANTIBODIES FOR TREATING CANCER 2011
  • Klinger-Amur Kristin
  • Zhuanno Aleksandra
  • Grene-Kossanel Veronik
  • Berger Sven
RU2595394C2
RECOMBINANT LENTIVIRAL VECTOR, HOST CELL TRANSDUCED WITH LENTIVIRAL VECTOR, METHODS FOR TRANSDUCTION AND USES THEREOF 2002
  • Trono Did'E
  • Viznerovich Matsej
RU2305708C2

RU 2 373 534 C2

Authors

Jokkers Ral'F

Kutjur'E Siril

Dates

2009-11-20Published

2003-02-25Filed